Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 60 2005 038 036.1 |
| 96 | EP file number | EAKZ | 10 19 3919.7 |
| 97 | EP publication number | EPN | 2314632 |
| 54 | Designation/title | TI | Aus Heparin abgeleitete Oligosaccharide |
| 51 | IPC main class | ICM
(ICMV) | C07H 3/06 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C08B 37/00 (2006.01), C12Q 1/527 (2006.01) |
| 22 | DE application date | DAT | Mar 22, 2005 |
| 96 | EP application date | EAT | Mar 22, 2005 |
| 43 | Date of first publication | OT | Apr 27, 2011 |
| Date of publication of grant | PET | Jan 23, 2013 |
| 71/73 | Applicant/owner | INH | Aventis Pharma S.A., Antony, FR |
| 72 | Inventor | IN | Mourier, Pierre, 75013, Paris, FR; Viskov, Christian, 75013, Paris, FR |
| Address for service | | Aventis Pharma S.A., 92160 ANTONY, FR |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| EP
04290791
Mar 24, 2004
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002314632
Searchable text:
EP000002314632
Original document:
EP000002314632B1
Searchable text:
EP000002314632B1 |
| 43 | Date of first publication | EVT | Apr 27, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Jun 9, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2021
(Show all update days)(Hide all update days)- Jan 5, 2021; Jan 13, 2016; Nov 16, 2015; Jul 18, 2015; Apr 29, 2014; Apr 8, 2014; Feb 13, 2014; Jan 3, 2014; Apr 10, 2013; Mar 29, 2013; Mar 21, 2013; Jan 26, 2013; Jan 24, 2013; Sep 1, 2011; Jun 10, 2011
- Historical data not available for this/these date(s)
- Jun 9, 2011
- Date of the first transfer into DPMAregister
|
